| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2003 | WO2003101389A2 Relief of aids symptoms |
| 12/11/2003 | WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | WO2003101384A2 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
| 12/11/2003 | WO2003101383A2 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| 12/11/2003 | WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 12/11/2003 | WO2003101380A2 Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors |
| 12/11/2003 | WO2003101379A2 Pyranoindazoles and their use for the treatment of glaucoma |
| 12/11/2003 | WO2003101378A2 Pharmaceutical formulation in a drug delivery system and process for preparing the same |
| 12/11/2003 | WO2003101376A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 12/11/2003 | WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof |
| 12/11/2003 | WO2003101374A2 Use of new etonogestrel esters |
| 12/11/2003 | WO2003101373A2 Thiazolidinedione derivatives in therapeutic and prophylactic methods |
| 12/11/2003 | WO2003101358A1 Implantable polymeric device for sustained release of buprenorphine |
| 12/11/2003 | WO2003101356A1 Personal care article and method for inhibiting attachment of yeast to skin |
| 12/11/2003 | WO2003101281A2 Method for reducing obstructive hydrocephalus |
| 12/11/2003 | WO2003101276A2 Protective effects of pde-5 inhibitors |
| 12/11/2003 | WO2003101224A1 Dietary method for modulatng glucose metabolism and associated conditions and increasing longevity |
| 12/11/2003 | WO2003101218A1 Process for producing lacturose-containing powder composition, lacturose-containing powder composition obtained by the process and feed additive |
| 12/11/2003 | WO2003101217A1 Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 12/11/2003 | WO2003101199A1 Combination therapy for rna virus infections involving ribavirin and impdh inhibitors |
| 12/11/2003 | WO2003101196A1 Antimicrobial envelopes |
| 12/11/2003 | WO2003101176A2 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 12/11/2003 | WO2003092790A3 Methods for increasing the therapeutic response to electroconvulsive therapy ('ect') |
| 12/11/2003 | WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 12/11/2003 | WO2003080630A3 Phosphate transport inhibitors |
| 12/11/2003 | WO2003080566A3 Hif hydroxylase inhibitors |
| 12/11/2003 | WO2003075904A3 Cyclodextrin complexed artemisinins |
| 12/11/2003 | WO2003063781A3 Substituted imidazoles as cannabinoid receptor modulators |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | WO2003057202A8 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation |
| 12/11/2003 | WO2003053347A3 Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections |
| 12/11/2003 | WO2003051300A3 Metal complexes and formulations of rifamycin analogues and uses therof |
| 12/11/2003 | WO2003051289A3 Solubilized topoisomerase poison agents |
| 12/11/2003 | WO2003051180A3 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 12/11/2003 | WO2003050190A3 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 12/11/2003 | WO2003048117A3 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
| 12/11/2003 | WO2003043632A3 Use of bisindolmaleimide and gemcitabine for the treatment of cancer |
| 12/11/2003 | WO2003043584A3 Engineered liposomal particles containing core-loaded pro-drugs for the controlled release of camptothecins |
| 12/11/2003 | WO2003037166A3 Devices and methods for the restoration of a spinal disc |
| 12/11/2003 | WO2003032912A3 Treatment of cns disorders using cns target modulators |
| 12/11/2003 | WO2003030928A3 Antitumor preparation |
| 12/11/2003 | WO2003029825A3 Method for predicting the sensitivity to chemotherapy |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 12/11/2003 | WO2003028674A3 Method for stimulating hair growth by administering vitamin d analogs |
| 12/11/2003 | WO2003027090A3 Bicyclic heterocycles as rxr ligands |
| 12/11/2003 | WO2003026564A3 Pharmaceutical compositions for the treatment of urinary disorders |
| 12/11/2003 | WO2003024958A3 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles |
| 12/11/2003 | WO2003024926A3 Methods and compositions of novel triazine compounds |
| 12/11/2003 | WO2003024395A3 Linked biaryl compounds |
| 12/11/2003 | WO2003022216A3 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 12/11/2003 | WO2003018014A9 Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2003011226A3 Products and drug delivery vehicles |
| 12/11/2003 | WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2003000241A3 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 12/11/2003 | WO2002100825A3 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances |
| 12/11/2003 | WO2002094273A3 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways |
| 12/11/2003 | WO2002094176A3 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments |
| 12/11/2003 | WO2002092552A3 Benzamidoacetonitriles and their use as antiparasitics |
| 12/11/2003 | WO2002091858A8 Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| 12/11/2003 | WO2002089853A3 Compositions having enhanced pharmacokinetic characteristics |
| 12/11/2003 | WO2002089791A3 Acne treatment with lipooxigenase inhibitors |
| 12/11/2003 | WO2002088114A3 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders |
| 12/11/2003 | WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 12/11/2003 | WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells |
| 12/11/2003 | WO2002085925A3 Melanocortin receptor ligands |
| 12/11/2003 | WO2002083067A3 Prodrugs via acylation with cinnamate |
| 12/11/2003 | WO2002080883A3 Method and composition for solubilising a biologically active compound with low water solubility |
| 12/11/2003 | WO2002078648A3 Topical composition comprising an antifungal |
| 12/11/2003 | WO2002064788A3 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2002062778A3 Anti-thrombotic compounds, production and use thereof as medicaments |
| 12/11/2003 | WO2002060383A3 Cancer therapy |
| 12/11/2003 | WO2002053149A3 Medicament containing a polyamine as an active substance |
| 12/11/2003 | WO2002048165A8 Antiviral agents for treatment of flaviviridae infections |
| 12/11/2003 | WO2002041884A8 Inhibitors of abc drug transporters at the blood-brain barrier |
| 12/11/2003 | WO2002008174A8 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229390 On-stent delivery of pyrimidines and purine analogs |
| 12/11/2003 | US20030229231 Forming chelate compounds |
| 12/11/2003 | US20030229226 Cathepsin cysteine protease inhibitors |
| 12/11/2003 | US20030229220 Oligomer phosphoramidite compositions and processes for synthesizing the same |
| 12/11/2003 | US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders |
| 12/11/2003 | US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 12/11/2003 | US20030229147 Anticancer agents; triarylmethane dye |
| 12/11/2003 | US20030229145 Analgesics; amino acid drug |
| 12/11/2003 | US20030229144 Anti-epileptogenic agents |
| 12/11/2003 | US20030229143 Use of a retinoid type compound to modulate in vivo the decoupling activity of the protein UCP2 |
| 12/11/2003 | US20030229142 Feed additive; stability, bioavailability; vision defects, anticancer agents, cardiovascular disorders |
| 12/11/2003 | US20030229141 N-acetyl cysteine and its topical use |
| 12/11/2003 | US20030229140 Plant extracts; chlorogenic acid |
| 12/11/2003 | US20030229138 Aza hydroxylated ethyl amine compounds utility |
| 12/11/2003 | US20030229137 Methods of inhibiting osteoclast activity |
| 12/11/2003 | US20030229136 Anticancer agents; antiproliferative agents |
| 12/11/2003 | US20030229134 Methods for stimulating nervous system regeneration and repair by inhibiting phosphodiesterase type 4 |
| 12/11/2003 | US20030229133 Amidine inhibitors of serine proteases |
| 12/11/2003 | US20030229130 Imidazolinylmethyl aralkylsulfonamides |
| 12/11/2003 | US20030229127 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 12/11/2003 | US20030229124 Lipid peroxide-lowering compositions |